Clinical Trial Detail

NCT ID NCT03608631
Title iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation
Recruitment Not yet recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors M.D. Anderson Cancer Center
Indications

pancreatic ductal adenocarcinoma

Therapies

iExosomes

Age Groups: senior adult

No variant requirements are available.